Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrady Regulatory News (BRY)

  • There is currently no data for BRY

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Recommended Mandatory Final Cash Offer

19 Nov 2019 07:00

RNS Number : 8165T
Hanover Acquisition Limited
19 November 2019
 

Recommended Mandatory Final Cash Offer

for

Brady plc ("Brady")

by

Hanover Acquisition Limited ("Hanover Bidco")

(an investment vehicle ultimately wholly owned

by Hanover Active Equity Fund II,

S.C.A. SICAV-RAIF)

 

 

On 18 November 2019, Hanover Bidco announced a recommended revised final cash offer of 18 pence in cash for each Brady Share (the "Revised Offer"). Pursuant to subsequent share purchases later the same day by Hanover Bidco ("Share Purchases"), the Revised Offer became a recommended mandatory final cash offer ("Mandatory Offer") for the entire issued and to be issued share capital of Brady, not already held by Hanover Bidco (or any persons acting in concert with it), at a price of 18 pence per Brady Share. The Mandatory Offer is final and will not be increased.

 

Level of acceptances

 

As at 3.00pm (London time) on 18 November 2019 (the latest practicable date prior to the publication of this announcement), Hanover Bidco had received valid acceptances of the Offer in respect of 1,140,344 Brady Shares (representing approximately 1.37 per cent. of the existing issued share capital of Brady). In addition, via the Share Purchases, Hanover Bidco has contracted to acquire 46,865,018 Brady Shares (representing approximately 56.21 per cent. of the existing issued share capital of Brady). The Share Purchases are expected to settle on Wednesday 20 November 2019 on a T+2 basis, and as such Hanover Bidco expects the Mandatory Offer to go wholly unconditional on the same day.

 

 

Terms and expressions used in this announcement shall, unless defined herein or unless the context otherwise requires, have the same meanings as given to them in the Offer Document, a copy of which is available on Hanover Bidco's website at www.hanoverinvestors.com and Brady's website at www.bradyplc.com.

 

Enquiries:

 

Hanover Investors Management LLP

Matthew Peacock Tel: +44 (0) 20 7766 8400

Fred Lundqvist

Panmure Gordon (UK) Limited (financial adviser to Hanover Bidco)

Dominic Morley Tel: +44(0)20 7886 2500

Nicholas Harland

Charles Leigh-Pemberton

Brady plc

Carmen Carey Tel: +44(0)20 3301 1200

Martin Thorneycroft

Cenkos Securities plc (financial adviser and nominated adviser to Brady)

Ben Jeynes Tel: +44(0)20 7397 8900

Nick Wells

Further information

 

This announcement is not intended to and does not constitute, or form part of, any offer to sell or subscribe for or an invitation to purchase or subscribe for any securities or the solicitation of any vote or approval in any jurisdiction pursuant to the Mandatory Offer or otherwise, nor shall there be any sale, issuance or transfer of securities of Brady in any jurisdiction in contravention of applicable law. This announcement does not constitute a prospectus or equivalent document.

 

Any acceptance or other response to the Mandatory Offer should only be made on the basis of the information contained in the Offer Document and the Form of Acceptance. Brady Shareholders who have not yet accepted the Mandatory Offer are advised to read the formal documentation in relation to the Mandatory Offer carefully.

 

Panmure Gordon (UK) Limited, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting exclusively for Hanover Bidco and no-one else in connection with the Mandatory Offer and other matters referred to in this announcement and will not be responsible to anyone other than Hanover Bidco for providing the protections afforded to clients of Panmure Gordon nor for providing advice in relation to the Mandatory Offer, this announcement or any other matter referred to herein. Neither Panmure Gordon nor any of its subsidiaries, branches or affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Panmure Gordon in connection with this announcement, any statement contained herein or otherwise.

 

Overseas jurisdictions

 

The availability of the Mandatory Offer or the release, publication or distribution of this announcement in or into, jurisdictions other than the United Kingdom may be restricted by law and therefore persons into whose possession this announcement comes who are not resident in the United Kingdom should inform themselves about, and observe, any applicable restrictions. Brady Shareholders who are in any doubt regarding such matters should consult an appropriate independent adviser in the relevant jurisdiction without delay. Any failure to comply with such restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

This announcement has been prepared for the purposes of complying with English law and the Code and the information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws of jurisdictions outside the United Kingdom. The statements contained in this announcement are not to be construed as legal, business, financial or tax advice.

 

Notice to US shareholders of Brady Shares

 

It may be difficult for US holders of Brady securities to enforce their rights under and any claim arising out of the US federal securities laws, since Hanover Bidco and Brady are located outside the United States, and some or all of their officers and directors may be resident outside the United States. US Brady Shareholders may not be able to sue a non-US company or its officers or directors in a non-US court for violations of the US securities laws. Further, it may be difficult to compel a non-US company and its affiliates to subject themselves to a US court's judgement and a US court may lack jurisdiction over such persons.

 

The Mandatory Offer will be made for securities of an English company and is being made in the United States in compliance with, and in reliance on, Section 14(e) of the United States Securities Exchange Act of 1934 (the "Exchange Act"), Regulation 14E thereunder and the exemption therefrom provided by Rule 14d-1(d) under the Exchange Act. The Mandatory Offer is being made in the United States by Hanover Bidco and no one else. The Mandatory Offer is subject to disclosure and procedural requirements of the United Kingdom which are different from those in the United States. In addition, US investors should be aware that this announcement has been prepared in accordance with English law and the Code and applicable disclosure requirements, format and style thereunder, all of which differ from those in the United States. Furthermore, the payment and settlement procedures with respect to the Mandatory Offer will comply with the relevant UK rules, which differ from US payment and settlement procedures. Neither the United States Securities Exchange Commission, nor any securities commission of any state or other jurisdiction of the United States, has approved the Mandatory Offer or passed upon the adequacy or completeness of this announcement.

 

The receipt of cash pursuant to the Mandatory Offer may have tax consequences in the United States and under other applicable tax laws and such consequences, if any, are not described herein. US Brady Shareholders are urged to consult with their own legal, tax and financial advisors in connection with making a decision regarding the Mandatory Offer.

 

To the extent permitted by applicable law, in accordance with, and to the extent permitted by, the Code and normal UK market practice, Hanover Bidco or nominees or brokers of Hanover Bidco (acting as agents) or their respective affiliates may from time to time make certain purchases of, or arrangements to purchase, Brady Shares or other Brady securities outside the United States other than pursuant to the Mandatory Offer at any time prior to completion of the Mandatory Offer. These purchases may occur either in the open market at prevailing prices or in private transactions at negotiated prices. Any such purchases, or arrangements to purchase, will comply with all applicable requirements of the Code, the Listing Rules and Regulation 14E under the US Exchange Act including Rule 14e-5, to the extent applicable. In addition, in accordance with the Code, normal United Kingdom market practice and Rule 14e-5(b) of the Exchange Act, Panmure Gordon and Cenkos Securities plc will continue to act as connected exempt market maker or connected exempt principal trader in Brady Shares or other Brady securities on the London Stock Exchange. To the extent required to be disclosed in accordance with applicable regulatory requirements, information about any such purchases and activities, including without limitation, such purchases and activities by the connected exempt market maker or connected exempt principal trader, will be disclosed on a next day basis to the Panel and will be available from any Regulatory Information Service, including the Regulatory News Service on the London Stock Exchange website, www.londonstockexchange.com. To the extent that such information is required to be publicly disclosed in the United Kingdom in accordance with applicable regulatory requirements, this information will as applicable also be publicly disclosed in the United States.

 

Publication of this announcement

 

A copy of this announcement will be available subject to certain restrictions relating to persons resident in Restricted Jurisdictions on www.hanoverinvestors.com and wwww.bradyplc.com by no later than 12 noon on the business day following the date of this announcement. The contents of Hanover Investors' website and Brady's website are not incorporated into and do not form part of this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
OUPGGGMUGUPBPGR
Date   Source Headline
19th Dec 201912:52 pmRNSTR-1: Notification of Major Holdings
13th Dec 201912:55 pmRNSTR-1: Notification of Major Holdings
9th Dec 20199:17 amRNSDirectorate Changes
6th Dec 20197:00 amRNSOffer Update
5th Dec 20195:30 pmRNSBrady
5th Dec 20198:23 amRNSCancellation from Trading on AIM
5th Dec 20197:00 amRNSLevel of acceptances
4th Dec 20194:33 pmRNSTR-1: Notification of Major Holdings
21st Nov 20194:45 pmRNSDirectorate Changes
21st Nov 20194:40 pmRNSDirectorate Changes
21st Nov 20192:35 pmRNSNew £5.0 million Loan Agreement
21st Nov 20199:46 amRNSForm 8.5 (EPT/NON-RI)
21st Nov 20199:08 amRNSForm 8.5 (EPT/RI)
21st Nov 20197:00 amRNSTR-1: Notification of Major Holdings
20th Nov 20194:22 pmRNSMandatory Final Cash Offer
20th Nov 20199:51 amRNSForm 8.5 (EPT/NON-RI)
19th Nov 20193:30 pmRNSForm 8.3 - Brady Plc
19th Nov 20193:03 pmRNSTR-1: Notification of Major Holdings
19th Nov 20192:55 pmRNSTR-1: Notification of Major Holdings
19th Nov 201911:18 amGNWForm 8.3 - Brady plc
19th Nov 20199:25 amRNSForm 8.5 (EPT/NON-RI)
19th Nov 20197:00 amRNSRecommended Mandatory Final Cash Offer
18th Nov 20195:09 pmRNSForm 8 (DD) - Hanover Acquisition Limited
18th Nov 20194:34 pmRNSTR-1: Notification of Major Holdings
18th Nov 20193:08 pmRNSForm 8.3 - Brady Plc
18th Nov 20192:05 pmRNSSecond Price Monitoring Extn
18th Nov 20192:00 pmRNSPrice Monitoring Extension
18th Nov 20191:08 pmRNSRecommended Mandatory Final Cash Offer
18th Nov 201910:37 amRNSRecommended Revised Final Cash Offer
18th Nov 20199:00 amRNSStatement re Possible Offer
18th Nov 20197:00 amRNSFirst Closing Date and Extension to Offer
15th Nov 20191:05 pmPRNForm 8.3 - Brady Plc
15th Nov 20198:54 amRNSForm 8.5 (EPT/NON-RI)
14th Nov 201911:17 amPRNForm 8.3 - Brady Plc
13th Nov 20194:40 pmRNSNew £3.0 million Loan Agreement
12th Nov 20191:18 pmRNSForm 8.5 (EPT/NON-RI)
11th Nov 201911:05 amRNSLoan Agreement
8th Nov 20199:09 amRNSForm 8.5 (EPT/NON-RI)
5th Nov 20193:19 pmBUSForm 8.3 - Brady Plc
5th Nov 20193:18 pmBUSForm 8.3 - Brady Plc
1st Nov 201910:16 amBUSForm 8.3 - Brady Plc
31st Oct 20193:21 pmBUSForm 8.3 - Brady Plc
30th Oct 20193:03 pmBUSFORM 8.3 - BRADY PLC
30th Oct 20192:47 pmBUSForm 8.3 - Brady Plc
30th Oct 20199:55 amRNSForm 8.5 (EPT/NON-RI)
29th Oct 20193:15 pmRNSForm 8.3 - Brady PLC
28th Oct 20193:15 pmRNSForm 8.3 - Brady PLC
28th Oct 20193:01 pmRNSTR-1: Notification of Major Holdings
28th Oct 201910:45 amRNSForm 8.5 (EPT/NON-RI)
25th Oct 20193:20 pmRNSForm 8.3 - Brady PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.